Variant report
Variant | esv3329014 |
---|---|
Chromosome Location | chr5:29088244-29117762 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:88)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr5:29114649-29114850 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr5:29089739-29090287 | K562 | blood: | n/a | n/a |
3 | BATF | chr5:29099732-29100010 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr5:29099772-29100098 | GM12878 | blood: | n/a | n/a |
5 | BHLHE40 | chr5:29089838-29090224 | K562 | blood: | n/a | n/a |
6 | BHLHE40 | chr5:29114706-29114820 | K562 | blood: | n/a | n/a |
7 | CCNT2 | chr5:29089941-29090240 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr5:29096216-29096495 | Hela-S3 | cervix: | n/a | chr5:29096332-29096343 chr5:29096327-29096344 chr5:29096330-29096343 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096330-29096341 |
9 | CEBPB | chr5:29096209-29096500 | HepG2 | liver: | n/a | chr5:29096332-29096343 chr5:29096327-29096344 chr5:29096330-29096343 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096330-29096341 |
10 | CEBPB | chr5:29096282-29096449 | H1-hESC | embryonic stem cell: | n/a | chr5:29096332-29096343 chr5:29096327-29096344 chr5:29096330-29096343 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096330-29096341 |
11 | CEBPB | chr5:29096184-29096509 | IMR90 | lung: | n/a | chr5:29096332-29096343 chr5:29096327-29096344 chr5:29096330-29096343 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096330-29096341 |
12 | CEBPB | chr5:29096194-29096516 | A549 | lung: | n/a | chr5:29096332-29096343 chr5:29096327-29096344 chr5:29096330-29096343 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096330-29096341 |
13 | CEBPB | chr5:29096172-29096477 | K562 | blood: | n/a | chr5:29096332-29096343 chr5:29096327-29096344 chr5:29096330-29096343 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096332-29096341 chr5:29096330-29096341 |
14 | CHD1 | chr5:29095636-29095675 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | CHD2 | chr5:29114366-29114830 | Hela-S3 | cervix: | n/a | n/a |
16 | CTCF | chr5:29115340-29115490 | BE2_C | brain: | n/a | n/a |
17 | CTCF | chr5:29106000-29106150 | GM06990 | blood: | n/a | n/a |
18 | CTCF | chr5:29115506-29115575 | K562 | blood: | n/a | n/a |
19 | CTCF | chr5:29093430-29093630 | K562 | blood: | n/a | n/a |
20 | CTCF | chr5:29115512-29115586 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr5:29106085-29106127 | GM10266 | blood: | n/a | n/a |
22 | CTCF | chr5:29115508-29115587 | MCF-7 | breast: | n/a | n/a |
23 | CTCF | chr5:29115499-29115602 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr5:29115472-29115646 | Hela-S3 | cervix: | n/a | n/a |
25 | CUX1 | chr5:29089709-29090142 | K562 | blood: | n/a | n/a |
26 | E2F4 | chr5:29107595-29107608 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | ELK1 | chr5:29114442-29114450 | Hela-S3 | cervix: | n/a | n/a |
28 | EP300 | chr5:29090086-29090156 | K562 | blood: | n/a | n/a |
29 | EP300 | chr5:29099639-29100030 | GM12878 | blood: | n/a | n/a |
30 | EP300 | chr5:29099823-29100001 | GM12878 | blood: | n/a | n/a |
31 | EP300 | chr5:29114653-29114819 | K562 | blood: | n/a | n/a |
32 | FOS | chr5:29093252-29093447 | HUVEC | blood vessel: | n/a | n/a |
33 | FOXP2 | chr5:29114481-29114820 | SK-N-MC | brain: | n/a | n/a |
34 | GATA2 | chr5:29114582-29114857 | K562 | blood: | n/a | n/a |
35 | GATA2 | chr5:29089775-29090203 | K562 | blood: | n/a | n/a |
36 | GTF2F1 | chr5:29101640-29101643 | K562 | blood: | n/a | n/a |
37 | MAFK | chr5:29109852-29109923 | Hela-S3 | cervix: | n/a | n/a |
38 | MAFK | chr5:29107501-29107934 | HepG2 | liver: | n/a | n/a |
39 | MAFK | chr5:29107622-29107848 | HepG2 | liver: | n/a | n/a |
40 | MAX | chr5:29114504-29114694 | Hela-S3 | cervix: | n/a | n/a |
41 | MAX | chr5:29114918-29114921 | Hela-S3 | cervix: | n/a | n/a |
42 | MAZ | chr5:29114636-29114803 | K562 | blood: | n/a | n/a |
43 | MAZ | chr5:29114421-29114976 | Hela-S3 | cervix: | n/a | n/a |
44 | MXI1 | chr5:29100277-29100321 | GM12878 | blood: | n/a | n/a |
45 | MYC | chr5:29090015-29090201 | NB4 | blood: | n/a | n/a |
46 | MYC | chr5:29097206-29097212 | NB4 | blood: | n/a | n/a |
47 | MYC | chr5:29107217-29107230 | H1-hESC | embryonic stem cell: | n/a | n/a |
48 | MYC | chr5:29089701-29089741 | NB4 | blood: | n/a | n/a |
49 | MYC | chr5:29107144-29107181 | H1-hESC | embryonic stem cell: | n/a | n/a |
50 | NFIC | chr5:29099682-29100093 | GM12878 | blood: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDH6-12 | chr5:29105449-29105545 | NONHSAT100833 |
2 | lnc-CDH9-14 | chr5:29105675-29106968 | NONHSAT100834 |
3 | lnc-CDH6-11 | chr5:29106999-29107219 | NONHSAT100835 |
4 | lnc-CDH6-12 | chr5:29104987-29105152 | NONHSAT100833 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000270430 | TF binding region |
ENSG00000248687 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540208311 | chr5:29090203-29090204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564748261 | chr5:29090262-29090263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573320737 | chr5:29090305-29090306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373053809 | chr5:29090319-29090320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562221169 | chr5:29090333-29090334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377498910 | chr5:29090356-29090357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144633009 | chr5:29090376-29090377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188665081 | chr5:29090377-29090378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554522125 | chr5:29090413-29090414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550774365 | chr5:29090416-29090417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562510973 | chr5:29090422-29090423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532947564 | chr5:29090427-29090428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376600656 | chr5:29090496-29090497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559452508 | chr5:29090502-29090503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs180800070 | chr5:29090539-29090540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183773420 | chr5:29090540-29090541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79690329 | chr5:29090560-29090561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541260343 | chr5:29095462-29095463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559997078 | chr5:29095488-29095489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146069752 | chr5:29095514-29095515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138866855 | chr5:29095516-29095517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563703214 | chr5:29095552-29095553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530915651 | chr5:29095558-29095559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs57319851 | chr5:29095583-29095584 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs564570256 | chr5:29095589-29095590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115120897 | chr5:29095590-29095591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560523428 | chr5:29095638-29095639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371108059 | chr5:29095647-29095648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193967 | chr5:29095648-29095649 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs190656106 | chr5:29095667-29095668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10434568 | chr5:29095681-29095682 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs181121652 | chr5:29095690-29095691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568547175 | chr5:29095763-29095764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549471395 | chr5:29095792-29095793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539036024 | chr5:29095802-29095803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557476025 | chr5:29095815-29095816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185770356 | chr5:29095835-29095836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142795534 | chr5:29095853-29095854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553254413 | chr5:29095860-29095861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575095829 | chr5:29095905-29095906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189744509 | chr5:29095924-29095925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542318318 | chr5:29095933-29095934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575758225 | chr5:29095944-29095945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546174010 | chr5:29095945-29095946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62352760 | chr5:29095957-29095958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76789262 | chr5:29096004-29096005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115262672 | chr5:29096005-29096006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373839821 | chr5:29096123-29096124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2220602 | chr5:29096126-29096127 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs529069779 | chr5:29096141-29096142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Bipolar disorder | 19114987 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29090200-29090600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
2 | chr5:29095400-29095800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr5:29095600-29096000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr5:29095600-29096000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr5:29095800-29096200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:29097000-29097400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr5:29102600-29103600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:29105600-29106600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr5:29105800-29106600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr5:29106000-29106600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr5:29106200-29106600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr5:29107000-29107400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr5:29109200-29111200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr5:29111200-29112200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:29112200-29112600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr5:29112600-29113000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr5:29113000-29113800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr5:29113800-29114000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr5:29113800-29114000 | Enhancers | Hela-S3 | cervix |
20 | chr5:29114000-29114400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr5:29114000-29115000 | Flanking Active TSS | Hela-S3 | cervix |
22 | chr5:29114000-29115400 | Enhancers | K562 | blood |
23 | chr5:29114200-29114800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr5:29114400-29114800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
25 | chr5:29114400-29116000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr5:29115000-29115600 | Enhancers | Hela-S3 | cervix |
27 | chr5:29116000-29116200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
28 | chr5:29116200-29116400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |